Literature DB >> 20155434

Prolonged ovalbumin challenge facilitates Th17 polarization in sensitized mice.

Qing Wang1, Hequan Li, Zhiyuan Zhang, Yinan Yao, Jianying Zhou.   

Abstract

OBJECTIVE AND
DESIGN: In this study, we explored whether prolonged ovalbumin (OVA) exposure in sensitized mice created an environment suitable for Th17 differentiation.
MATERIALS AND METHODS: BALB/c and C57BL/6 mice (n = 36), after intraperitoneal OVA sensitization on days 0 and 12, received prolonged OVA aerosol challenges up to day 55. Airway inflammatory cell levels, cytokine profiles, and Th17 cell infiltration were evaluated after sacrifice.
RESULTS: Prolonged OVA challenge caused inflammation that was characterized by raised influxes of airway macrophages and neutrophils. Following long-term exposure, Th17 cytokines and Th17 cell numbers progressively increased in the lung (P < 0.05) along with increased production of Th17 polarization-related factors, including TGF-beta, IL-6, and IL-23. The lineage-specific transcription factor for Th17 subsets, RORgammat, displayed similar upregulation throughout the OVA challenge (P < 0.05).
CONCLUSIONS: Prolonged OVA challenge induces an environment that facilitates Th17 polarization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155434     DOI: 10.1007/s00011-010-0162-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  42 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge.

Authors:  Rui He; Michiko K Oyoshi; Haoli Jin; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

3.  Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma.

Authors:  Sook Young Lee; Jin Sook Kim; Jung Mi Lee; Soon Seok Kwon; Kwan Hyung Kim; Hwa Sik Moon; Jung Sub Song; Sung Hark Park; Young Kyoon Kim
Journal:  Pulm Pharmacol Ther       Date:  2006-10-20       Impact factor: 3.410

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

5.  Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation.

Authors:  Svetlana Sergejeva; Stefan Ivanov; Jan Lötvall; Anders Lindén
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-18       Impact factor: 6.914

6.  Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway.

Authors:  Sarah J McMillan; Georgina Xanthou; Clare M Lloyd
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

7.  Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor.

Authors:  Filip K Swirski; Dusan Sajic; Clinton S Robbins; Beata U Gajewska; Manel Jordana; Martin R Stämpfli
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10.

Authors:  Lucila G G Pacífico; Fábio A V Marinho; Cristina T Fonseca; Michele M Barsante; Vanessa Pinho; Policarpo A Sales-Junior; Luciana S Cardoso; Maria Ilma Araújo; Edgar M Carvalho; Geovanni D Cassali; Mauro M Teixeira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  Interleukin-17 is a negative regulator of established allergic asthma.

Authors:  Silvia Schnyder-Candrian; Dieudonnée Togbe; Isabelle Couillin; Isabelle Mercier; Frank Brombacher; Valérie Quesniaux; Francois Fossiez; Bernhard Ryffel; Bruno Schnyder
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

10.  Prolonged allergen challenge in mice leads to persistent airway remodelling.

Authors:  S J McMillan; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2004-03       Impact factor: 5.018

View more
  3 in total

1.  Fractionated irradiations lead to chronic allergic airway inflammation through increasing the influx of macrophages.

Authors:  Hae-Ran Park; Sung-Kee Jo; Dong-Kyung Yu; Uhee Jung
Journal:  Inflamm Res       Date:  2012-08-23       Impact factor: 4.575

Review 2.  Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma.

Authors:  Yuko Morishima; Satoshi Ano; Yukio Ishii; Shigeo Ohtsuka; Masashi Matsuyama; Mio Kawaguchi; Nobuyuki Hizawa
Journal:  Clin Dev Immunol       Date:  2013-12-23

3.  Hyperoxia promotes polarization of the immune response in ovalbumin-induced airway inflammation, leading to a TH17 cell phenotype.

Authors:  Akinori C Nagato; Frank S Bezerra; André Talvani; Beatriz J Aarestrup; Fernando M Aarestrup
Journal:  Immun Inflamm Dis       Date:  2015-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.